Works matching IS 13594184 AND DT 2009 AND VI 14 AND IP 12

Results: 17

Clearance mechanisms of Alzheimer's amyloid-β peptide: implications for therapeutic design and diagnostic tests.

Published in:

2009

By:

Bates, K. A.;
Verdile, G.;
Li, Q.-X.;
Ames, D.;
Hudson, P.;
Masters, C. L.;
Martins, R. N.

Publication type:

Correction Notice

Differential effects on T-cell function following exposure to serum from schizophrenia smokers.

Published in:

2009

By:

Herberth, M.;
Krzyszton, D. N.;
Koethe, D.;
Craddock, M. R.;
Bulger, E.;
Schwarz, E.;
Guest, P.;
Leweke, F. M.;
Bahn, S.

Publication type:

Correction Notice

Developmental etiology for neuroanatomical and cognitive deficits in mice overexpressing Gαs, a G-protein subunit genetically linked to schizophrenia.

Published in:

2009

By:

Kelly, M. P.;
Stein, J. M.;
Vecsey, C. G.;
Favilla, C.;
Yang, X.;
Bizily, S. F.;
Esposito, M. F.;
Wand, G.;
Kanes, S. J.;
Abel, T.

Publication type:

Correction Notice

Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-α and ribavirin treatment.

Published in:

2009

By:

Bull, S. J.;
Huezo-Diaz, P.;
Binder, E. B.;
Cubells, J. F.;
Ranjith, G.;
Maddock, C.;
Miyazaki, C.;
Alexander, N.;
Hotopf, M.;
Cleare, A. J.;
Norris, S.;
Cassidy, E.;
Aitchison, K. J.;
Miller, A. H.;
Pariante, C. M.

Publication type:

Correction Notice

Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-α and ribavirin treatment.

Published in:

Molecular Psychiatry, 2009, v. 14, n. 12, p. 1095, doi. 10.1038/mp.2008.48

By:

Bull, S. J.;
Huezo-Diaz, P.;
Binder, E. B.;
Cubells, J. F.;
Ranjith, G.;
Maddock, C.;
Miyazaki, C.;
Alexander, N.;
Hotopf, M.;
Cleare, A. J.;
Norris, S.;
Cassidy, E.;
Aitchison, K. J.;
Miller, A. H.;
Pariante, C. M.

Publication type:

Article

Identifying blood biomarkers for mood disorders using convergent functional genomics.

Published in:

2009

By:

Le-Niculescu, H.;
Kurian, S. M.;
Yehyawi, N.;
Dike, C.;
Patel, S. D.;
Edenberg, H. J.;
Tsuang, M. T.;
Salomon, D. R.;
Nurnberger, J. I.;
Niculescu, A. B.

Publication type:

Correction Notice

Genomewide association for schizophrenia in the CATIE study: results of stage 1.

Published in:

2009

By:

Sullivan, P. F.;
Lin, D.;
Tzeng, J.-Y.;
van den Oord, E.;
Perkins, D.;
Stroup, T. S.;
Wagner, M.;
Lee, S.;
Wright, F. A.;
Zou, F.;
Liu, W.;
Downing, A. M.;
Lieberman, J.;
Close, S. L.

Publication type:

Correction Notice

The association between smoking and subsequent suicide-related outcomes in the National Comorbidity Survey panel sample.

Published in:

Molecular Psychiatry, 2009, v. 14, n. 12, p. 1132, doi. 10.1038/mp.2008.78

By:

Kessler, R. C.;
Borges, G.;
Sampson, N.;
Miller, M.;
Nock, M. K.

Publication type:

Article

Chronic stimulation of corticotropin-releasing factor receptor 1 enhances the anxiogenic response of the cholecystokinin system.

Published in:

2009

By:

Sherrin, T.;
Todorovic, C.;
Zeyda, T.;
Tan, C. H.;
Wong, P. T. H.;
Zhu, Y.-Z.;
Spiess, J.

Publication type:

Correction Notice

New neuron production can be increased in the hippocampus of aged rats following cannabinoid treatment.

Published in:

Molecular Psychiatry, 2009, v. 14, n. 12, p. 1067, doi. 10.1038/mp.2009.122

By:

Marchalant, Y.;
Brothers, H. M.;
Wenk, G. L.

Publication type:

Article

Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function.

Published in:

Molecular Psychiatry, 2009, v. 14, n. 12, p. 1083, doi. 10.1038/mp.2009.18

By:

Maycox, P. R.;
Kelly, F.;
Taylor, A.;
Bates, S.;
Reid, J.;
Logendra, R.;
Barnes, M. R.;
Larminie, C.;
Jones, N.;
Lennon, M.;
Davies, C.;
Hagan, J. J.;
Scorer, C. A.;
Angelinetta, C.;
Akbar, T.;
Hirsch, S.;
Mortimer, A. M.;
Barnes, T. R. E.;
de Belleroche, J.

Publication type:

Article

Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function.

Published in:

2009

By:

Maycox, P. R.;
Kelly, F.;
Taylor, A.;
Bates, S.;
Reid, J.;
Logendra, R.;
Barnes, M. R.;
Larminie, C.;
Jones, N.;
Lennon, M.;
Davies, C.;
Hagan, J. J.;
Scorer, C. A.;
Angelinetta, C.;
Akbar, M. T.;
Hirsch, S.;
Mortimer, A. M.;
Barnes, T. R. E.;
de Belleroche, J.

Publication type:

Correction Notice

Activation of brain interleukin-1β in schizophrenia.

Published in:

2009

By:

Söderlund, J.;
Schröder, J.;
Nordin, C.;
Samuelsson, M.;
Walther-Jallow, L.;
Karlsson, H.;
Erhardt, S.;
Engberg, G.

Publication type:

Letter

Detrimental effects of glucocorticoids on neuronal migration during brain development.

Published in:

Molecular Psychiatry, 2009, v. 14, n. 12, p. 1119, doi. 10.1038/mp.2009.60

By:

Fukumoto, K.;
Morita, T.;
Mayanagi, T.;
Tanokashira, D.;
Yoshida, T.;
Sakai, A.;
Sobue, K.

Publication type:

Article

Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain.

Published in:

2009

By:

Marchalant, Y.;
Brothers, H. M.;
Wenk, G. L.

Publication type:

Letter

The role of genetic variation in the causation of mental illness: an evolution-informed framework.

Published in:

Molecular Psychiatry, 2009, v. 14, n. 12, p. 1072, doi. 10.1038/mp.2009.85

By:

Uher, R.

Publication type:

Article

Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans.

Published in:

Molecular Psychiatry, 2009, v. 14, n. 12, p. 1105, doi. 10.1038/mp.2009.92

By:

Dong, C.;
Wong, M.-L.;
Licinio, J.

Publication type:

Article